Skip to content

Study on the Impact of PEG-rhGH Treatment on the Immune Function of Children with Short Stature

Study on the Impact of PEG-rhGH Treatment on the Immune Function of Children with Short Stature

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095743
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

short stature syndrome

Interventions

Non PEG-rhGH treatment group:None

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: A. Meet the clinical diagnostic criteria for short stature (the height at the time of enrollment is lower than the 3rd percentile or X - 2SD of normal children of the same age and gender); B. No fever, no history of medication use, and no history of contact with infectious diseases within the recent 4 weeks; C. No history of blood transfusion, no history of allergic diseases, and no history of diseases in the blood system and immune system. D. Have not received growth hormone treatment in the past.

Exclusion criteria

Exclusion criteria: 1)Abnormalities in peripheral blood routine: Elevated or decreased white blood cell count, abnormal absolute values of neutrophils, lymphocytes and eosinophils. 2)Abnormalities in liver and kidney functions (ALT > 2 times the upper limit of the normal value, Cr > the upper limit of the normal value). 3)Not meeting the requirements for the use of growth hormone. 4)Other circumstances that investigators consider not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Single cell sequencing;

Secondary

MeasureTime frame
humoral immunity;Cytokines and Lymphocyte Subsets;

Countries

China

Contacts

Public ContactDing Yuan

Children's Hospital of Chongqing Medical University

18623570730@163.com+86 186 2357 0730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026